Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder – March 20, 2026

Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder – 2026

Advanced Multidisciplinary Management of Alcohol Use Disorder in Liver Transplantation

---

📦 Product Details

Format: 11+ Videos (.mp4)
PDFs: None Included
Course Date: March 20, 2026
Access: On-demand
Focus: Liver Transplantation & Alcohol Use Disorder (AUD)
Target Audience: Hepatologists, transplant specialists, addiction medicine professionals, and multidisciplinary transplant teams

---

🩺 Program Overview

Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder 2026 is a comprehensive educational program exploring the rapidly evolving management of patients with alcohol use disorder (AUD) who require liver transplantation.

This multidisciplinary course provides clinicians with evidence-based insights into the medical, psychosocial, ethical, and behavioral complexities surrounding alcohol-associated liver disease (ALD), transplantation candidacy, relapse prevention, and long-term post-transplant care.

Designed for physicians, surgeons, addiction specialists, mental health professionals, nurses, social workers, and allied healthcare providers, the program highlights modern treatment strategies, collaborative care models, emotional intelligence in transplant leadership, and emerging therapies including GLP-1 receptor agonists.

Participants will gain practical knowledge on patient selection, psychosocial assessment, addiction treatment integration, ethical decision-making, relapse risk management, and multidisciplinary transplant care aimed at improving patient survival and long-term outcomes.

---

🎯 Key Features

• Advanced liver transplantation and addiction medicine education
• Focus on alcohol-associated liver disease (ALD)
• Multidisciplinary transplant management strategies
• Evidence-based AUD treatment approaches
• Ethical and psychosocial transplant decision-making
• Relapse prevention and long-term support planning
• Emerging therapies including GLP-1 receptor agonists
• Real-world case discussions and expert panel sessions

---

📚 What You Will Learn

• Understand the pathophysiology of alcohol-related liver disease
• Evaluate candidates with AUD for liver transplantation
• Apply evidence-based relapse prevention strategies
• Integrate psychosocial and ethical considerations into transplant care
• Analyze the role of the intestinal microbiome in addiction
• Recognize risk factors for post-transplant alcohol relapse
• Implement multidisciplinary addiction treatment approaches
• Explore emerging therapies including GLP-1 agonists
• Improve inpatient and outpatient management of AUD patients
• Optimize long-term transplant outcomes and survival

---

🫀 Core Topics Covered

🍷 Alcohol Use Disorder & Liver Disease

• Alcohol-associated liver disease (ALD)
• Alcohol-associated hepatitis and transplantation
• Effects of alcohol on MASLD
• Alcohol and liver cancer
• Medical management of AUD in ALD
• Advanced liver disease progression

🩺 Liver Transplantation & Candidate Evaluation

• Liver transplantation candidacy in AUD
• Absolute contraindications for liver transplant in ALD
• The 6-month abstinence rule controversy
• Medical and psychosocial transplant evaluation
• Ethical challenges in transplant decision-making
• Transplant medical review board management

🧠 Addiction Medicine & Behavioral Health

• Managing individuals with AUD and addiction
• Outpatient community-based addiction treatment
• Emotional intelligence in transplant program leadership
• Behavioral relapse risk factors
• Integrated addiction treatment models
• Psychosocial support strategies

🧬 Gut-Liver Axis & Emerging Science

• Intestinal microbiome and addiction pathways
• Gut-liver axis interactions
• Dysbiosis and alcohol addiction
• GLP-1 receptor agonists and addiction treatment
• Metabolic dysfunction-associated steatotic liver disease (MASLD)
• Emerging biologic and pharmacologic therapies

🏥 Post-Transplant Management & Relapse Prevention

• Strategies to reduce alcohol relapse after transplantation
• Inpatient management of AUD post-transplant
• Long-term monitoring and support
• Multidisciplinary transplant follow-up
• Case-based management discussions
• Survival and outcome optimization

⚖️ Ethical & Multidisciplinary Challenges

• Ethical considerations in transplant eligibility
• Evaluation of critically ill transplant candidates
• Managing intubated transplant patients
• Team-based transplant decision-making
• Panel discussions on complex transplant cases
• Collaborative transplant care models

---

🎥 Featured Sessions

• Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder
• Emotional Intelligence and Managing a Transplant Program
• Managing Individuals with AUD and Addiction
• Alcohol-Associated Hepatitis and Liver Transplantation
• Effects of Alcohol on MASLD
• Intestinal Microbiome and Addiction
• Strategies to Reduce Alcohol Relapse After Liver Transplantation
• Medical Management of AUD in ALD
• GLP-1 Receptor Agonists and Addiction
• AUD and Kidney Transplantation
• Panel Discussion: Ethical and Clinical Challenges of Liver Transplantation

---

👨‍⚕️ Target Audience

• Hepatologists
• Gastroenterologists
• Transplant surgeons
• Addiction medicine specialists
• Psychiatrists and psychologists
• Internal medicine physicians
• Primary care physicians
• Social workers
• Nurses and transplant coordinators
• Allied health professionals involved in transplant care

---

🚀 Why This Course Stands Out

• Combines hepatology, transplantation, and addiction medicine in one program
• Strong focus on multidisciplinary patient-centered care
• Addresses real-world ethical and psychosocial challenges
• Includes emerging therapies and modern addiction science
• Practical guidance for relapse prevention and long-term management
• Features expert-led case discussions and panel sessions
• Covers both inpatient and outpatient transplant care strategies
• Ideal for clinicians managing complex alcohol-associated liver disease and transplantation cases